Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
American Society of Clinical Oncology (ASCO)
Online
2023-01-10
DOI
10.1200/jco.22.01239
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast cancer risks associated with missense variants in breast cancer susceptibility genes
- (2022) Leila Dorling et al. Genome Medicine
- Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
- (2021) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- A Population-Based Study of Genes Previously Implicated in Breast Cancer
- (2021) Chunling Hu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
- (2021) et al. NEW ENGLAND JOURNAL OF MEDICINE
- Race, ethnicity and risk of second primary contralateral breast cancer in the United States
- (2021) Gordon P. Watt et al. INTERNATIONAL JOURNAL OF CANCER
- Multigene assessment of genetic risk for women for two or more breast cancers
- (2021) Jeffrey N. Weitzel et al. BREAST CANCER RESEARCH AND TREATMENT
- Risk of Late-Onset Breast Cancer in Genetically Predisposed Women
- (2021) Nicholas J. Boddicker et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional analysis identifies damaging CHEK2 missense variants associated with increased cancer risk
- (2021) Rick ACM Boonen et al. CANCER RESEARCH
- Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast
- (2021) Siddhartha Yadav et al. JOURNAL OF CLINICAL ONCOLOGY
- Nomogram to predict contralateral breast cancer risk in breast cancer survivors
- (2021) Jiaci Tong et al. MEDICINE
- Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer
- (2020) Siddhartha Yadav et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation treatment, ATM, BRCA1/2, and CHEK2*1100delC pathogenic variants, and risk of contralateral breast cancer
- (2020) Anne S Reiner et al. JNCI-Journal of the National Cancer Institute
- Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
- (2020) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women
- (2020) Julie R Palmer et al. JNCI-Journal of the National Cancer Institute
- Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
- (2020) Iris Kramer et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Age-specific risks of incident, contralateral and ipsilateral breast cancer among 1776 Polish BRCA1 mutation carriers
- (2019) Jan Lubinski et al. BREAST CANCER RESEARCH AND TREATMENT
- Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers
- (2019) Joanne Kotsopoulos et al. BREAST CANCER RESEARCH AND TREATMENT
- Screening Guidelines Update for Average-Risk and High-Risk Women
- (2019) Cindy S. Lee et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women’s Environmental Cancer and Radiation Epidemiology Study
- (2018) Anne S. Reiner et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study
- (2018) Ellen R Copson et al. LANCET ONCOLOGY
- Risk factors for metachronous contralateral breast cancer:A systematic review and meta-analysis
- (2018) Delal Akdeniz et al. BREAST
- Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women
- (2018) Tae In Yoon et al. BREAST CANCER RESEARCH AND TREATMENT
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review
- (2016) X. Li et al. CLINICAL CANCER RESEARCH
- Contralateral breast cancer risk in relation to tumor morphology and age—in which patients is preoperative MRI justified?
- (2015) N. A. de Glas et al. BREAST CANCER RESEARCH AND TREATMENT
- Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis
- (2014) Esther Molina-Montes et al. BREAST
- Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
- (2014) M Kriege et al. BRITISH JOURNAL OF CANCER
- Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
- (2014) K. Metcalfe et al. BMJ-British Medical Journal
- Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
- (2011) K Metcalfe et al. BRITISH JOURNAL OF CANCER
- Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation inBRCA1orBRCA2
- (2010) Kathleen E. Malone et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now